2seventy bio, Inc. (TSVT)
NASDAQ: TSVT · IEX Real-Time Price · USD
4.790
+0.220 (4.81%)
At close: Jul 26, 2024, 4:00 PM
4.810
+0.020 (0.42%)
After-hours: Jul 26, 2024, 4:41 PM EDT

2seventy bio Revenue

2seventy bio had revenue of $12.44M in the quarter ending March 31, 2024, a decrease of -70.12%. This brings the company's revenue in the last twelve months to $71.20M, down -42.90% year-over-year. In the year 2023, 2seventy bio had annual revenue of $100.39M with 9.72% growth.

Revenue (ttm)
$71.20M
Revenue Growth
-42.90%
P/S Ratio
3.46
Revenue / Employee
$259,858
Employees
274
Market Cap
246.23M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023100.39M8.89M9.72%
Dec 31, 202291.50M36.97M67.81%
Dec 31, 202154.52M-193.60M-78.03%
Dec 31, 2020248.12M203.83M460.15%
Dec 31, 201944.30M-10.28M-18.84%
Dec 31, 2018 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
P3 Health Partners 1.35B
23andMe Holding Co. 219.64M
Semler Scientific 65.88M
Genfit 42.42M
Caribou Biosciences 33.40M
ClearPoint Neuro 26.16M
bluebird bio 21.73M
Revenue Rankings